From: Cost-effectiveness analysis for HbA1c test intervals to screen patients with type 2 diabetes based on risk stratification
Age group
30–44
45–59
60–74
BMI group
Underweight
10-year
3-year
Normal
6-year
Overweight
4-year
Obese